Negean Vandordaklou, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 13900 Parkview Ln, Apt 203, Southgate, MI 48195 Phone: 310-658-3213 |
Lekeysha Marie Robinson-royster, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 13667 Eureka Rd, Southgate, MI 48195 Phone: 734-530-6777 |
News Archive
Although the cause of Parkinson's disease remains a mystery, scientists now have a better understanding of the earliest stages of abnormal aggregation of a key disease-associated protein. The research, published by Cell Press online on April 6th in Biophysical Journal, provides new insight into the first steps in the formation of neurotoxic structures called Lewy bodies that are the hallmark of the Parkinson's brain.
Ablative Solutions, Inc., a privately-held clinical stage company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Peregrine System(TM) Infusion Catheter.
A bioinformatics expert at the IRCM, Benjamin Haibe-Kains, recently published an article stressing the importance of standardizing drug screening studies in the prestigious scientific journal Nature. The study supports the need for further development and standardization to improve the reproducibility of drug screening studies, as they are important in identifying new therapeutic agents and their potential combinations with existing drugs.
Sanofi US and POZEN Inc. announced the signing of an exclusive license agreement for the commercialization of POZEN's proprietary, investigational, coordinated-delivery tablets combining immediate-release omeprazole, a proton pump inhibitor, and enteric-coated aspirin in a single tablet ("PA"), PA8140 and PA32540.
Bone repair wasn't generally successful until the late 1800s. Until then, there were few options to repair major bone damage. Most materials don't have the functionality of bone and don't support blood vessels growing through them.
› Verified 9 days ago